• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats.

作者信息

Ness G C, Zhao Z

机构信息

Department of Biochemistry and Molecular Biology College of Medicine, University of South Florida, Tampa 33612.

出版信息

Arch Biochem Biophys. 1994 Nov 15;315(1):199-202. doi: 10.1006/abbi.1994.1490.

DOI:10.1006/abbi.1994.1490
PMID:7979399
Abstract

The effects of hypophysectomy and thyroid hormone treatment on the expression of the hepatic LDL receptor gene was studied in young male rats. Hypophysectomy lowered levels of LDL receptor mRNA and protein. It was found that increased levels of LDL receptor mRNA could be detected 30 min after giving hypophysectomized rats an intramuscular injection of 10 micrograms of L-triiodothyronine (T3) per 100 g of body weight. This dose of T3 also increased hepatic LDL receptor protein levels within 1 h. A T3 dose of only 0.25 microgram per 100 g increased LDL receptor mRNA levels more than threefold. The half-life of the hepatic LDL receptor mRNA was found to be about 30 min and was unaffected by T3. The data suggests that thyroid hormone acts physiologically to induce hepatic LDL receptor expression. This action may explain, in part, the hypocholesterolemic effect of the hormone.

摘要

相似文献

1
Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats.
Arch Biochem Biophys. 1994 Nov 15;315(1):199-202. doi: 10.1006/abbi.1994.1490.
2
Effect of thyroid hormone on hepatic cholesterol 7 alpha hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthetase and apolipoprotein A-I mRNA levels in hypophysectomized rats.
Biochem Biophys Res Commun. 1990 Nov 15;172(3):1150-6. doi: 10.1016/0006-291x(90)91568-d.
3
Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression.L-三碘甲状腺原氨酸及拟甲状腺素L-94901对血清脂蛋白水平以及肝脏低密度脂蛋白受体、3-羟基-3-甲基戊二酰辅酶A还原酶和载脂蛋白A-I基因表达的影响。
Biochem Pharmacol. 1998 Jul 1;56(1):121-9. doi: 10.1016/s0006-2952(98)00119-1.
4
Thyroid hormone rapidly increases cholesterol 7 alpha-hydroxylase mRNA levels in hypophysectomized rats.
Biochim Biophys Acta. 1994 Oct 6;1214(3):229-33. doi: 10.1016/0005-2760(94)90068-x.
5
Thyroid hormone and growth hormone interact to regulate insulin-like growth factor-I messenger ribonucleic acid and circulating levels in the rat.甲状腺激素与生长激素相互作用,调节大鼠体内胰岛素样生长因子-I信使核糖核酸及循环水平。
Endocrinology. 1989 Dec;125(6):2905-14. doi: 10.1210/endo-125-6-2905.
6
Activation of the hepatic LDL receptor promoter by thyroid hormone.甲状腺激素对肝脏低密度脂蛋白受体启动子的激活作用。
Biochim Biophys Acta. 2007 Sep;1771(9):1216-25. doi: 10.1016/j.bbalip.2007.05.001. Epub 2007 May 21.
7
Transcriptional regulation of rat hepatic low-density lipoprotein receptor and cholesterol 7 alpha hydroxylase by thyroid hormone.甲状腺激素对大鼠肝脏低密度脂蛋白受体和胆固醇7α羟化酶的转录调控。
Arch Biochem Biophys. 1995 Nov 10;323(2):404-8. doi: 10.1006/abbi.1995.0061.
8
Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic low density lipoprotein-receptor expression.垂体切除术后大鼠对膳食胆固醇的抗性丧失:生长激素的存在对肝脏低密度脂蛋白受体表达的重要性。
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8851-5. doi: 10.1073/pnas.90.19.8851.
9
Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone.脱氢表雄酮和甲状腺激素对大鼠CYP4A表达的调节
Mol Pharmacol. 1996 Feb;49(2):276-87.
10
Thyroid hormone stimulation of NADPH P450 reductase expression in liver and extrahepatic tissues. Regulation by multiple mechanisms.
J Biol Chem. 1992 Feb 15;267(5):3294-301.

引用本文的文献

1
KYLO-0603, a novel liver-targeting, thyroid hormone receptor-β agonist for the inhibition of MASH progression.KYLO-0603,一种新型的肝脏靶向性甲状腺激素受体-β激动剂,用于抑制MASH进展。
PLoS One. 2025 Sep 15;20(9):e0331768. doi: 10.1371/journal.pone.0331768. eCollection 2025.
2
Thyroid hormone and the Liver.甲状腺激素与肝脏
Hepatol Commun. 2024 Dec 20;9(1). doi: 10.1097/HC9.0000000000000596. eCollection 2025 Jan 1.
3
The Effects of Anti-thyroid Drugs on Lipoproteins and Insulin Resistance in Graves' Disease: A Randomized Clinical Trial.
抗甲状腺药物对格雷夫斯病患者脂蛋白及胰岛素抵抗的影响:一项随机临床试验
J Lipid Atheroscler. 2024 Sep;13(3):358-370. doi: 10.12997/jla.2024.13.3.358. Epub 2024 Jun 12.
4
AAV8-mediated overexpression of mPCSK9 in liver differs between male and female mice.AAV8 介导的 mPCSK9 在肝脏中的过表达在雄性和雌性小鼠之间存在差异。
Atherosclerosis. 2018 Nov;278:66-72. doi: 10.1016/j.atherosclerosis.2018.09.005. Epub 2018 Sep 8.
5
Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research.利用腺相关病毒-CRISPR 对 LDLR 进行体细胞编辑是动脉粥样硬化研究的有效工具。
Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):1997-2006. doi: 10.1161/ATVBAHA.118.311221.
6
GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.GC-1:一种在肝病中有多种治疗应用的甲状腺模拟物。
Gene Expr. 2017 Nov 27;17(4):265-275. doi: 10.3727/105221617X14968563796227. Epub 2017 Jun 13.
7
Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease.利用 CRISPR/Cas9 进行体细胞基因组编辑可产生并纠正代谢疾病。
Sci Rep. 2017 Mar 16;7:44624. doi: 10.1038/srep44624.
8
Using electroporation to identify hepatic LDL receptor promoter elements and transcription factors mediating activation of transcription by T.利用电穿孔法鉴定肝脏低密度脂蛋白受体启动子元件以及介导T激活转录的转录因子。
Appl Transl Genom. 2012 Oct 3;1:30-36. doi: 10.1016/j.atg.2012.08.001. eCollection 2012 Dec 1.
9
Thyroid Hormone Regulates the mRNA Expression of Small Heterodimer Partner through Liver Receptor Homolog-1.甲状腺激素通过肝受体同源物-1调节小异二聚体伴侣的 mRNA 表达。
Endocrinol Metab (Seoul). 2015 Dec;30(4):584-92. doi: 10.3803/EnM.2015.30.4.584. Epub 2015 Oct 20.
10
Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model.人源化小鼠模型中家族性高胆固醇血症的建立与挽救
Nat Commun. 2015 Jun 17;6:7339. doi: 10.1038/ncomms8339.